PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Servicio de Emergencias, Sanatorio Finochietto, Buenos Aires, Argentina. E-mail: ngalvalisi@sanatoriofinocheitto.com.\', \'Departamento de Investigación, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.\', \'Servicio de Infectología, Sanatorio Finochietto, Buenos Aires, Argentina.\', \'Servicio de Medicina Interna, Sanatorio Finochietto, Buenos Aires, Argentina.\', \'Unidad de Cuidados Intensivos, Sanatorio Finochietto, Buenos Aires, Argentina.\', \'Departamento de Medicina, Sanatorio Finochietto, Buenos Aires, Argentina.\']
?:citedBy
  • -1
?:creator
?:hasPublicationType
?:journal
  • Medicina
is ?:pmid of
?:pmid
?:pmid
  • 35037856
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.125
?:rankingScore_hIndex
  • 9
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab for COVID-19 treatment. An Argentine report.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35037856>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35037856>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all